Prevalence of Cardiac Arrhythmias and Distal Conduction Disorders in Patients With Chronic Chagas’ Disease and Elevated Autoantibodies Against M2 Muscarinic Acetylcholine Receptors

Chagas’ disease (ChD) is a parasitic disease endemic to regions of Latin America and with an increasingly global reach. Up to 30% of patients with ChD develop severe dilated cardiomyopathy, ventricular arrhythmias, conduction disorders and/or sudden cardiac death. Autoantibodies against M2 muscarini...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Current problems in cardiology 2021-06, Vol.46 (6), p.100820-100820, Article 100820
Hauptverfasser: Carbajales, Justo, Krishnan, Dhruv, Principato, Mario, Tomatti, Alejandro, Paolucci, Analía, Yoo, Hyun Sok, von Wulffen, Alejandra, Ciampi, Natalia, Tepper, Rita, Carradori, Jorge, Baranchuk, Adrian
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Chagas’ disease (ChD) is a parasitic disease endemic to regions of Latin America and with an increasingly global reach. Up to 30% of patients with ChD develop severe dilated cardiomyopathy, ventricular arrhythmias, conduction disorders and/or sudden cardiac death. Autoantibodies against M2 muscarinic acetylcholine receptors (M2 mAChR) have been implicated in the pathogenesis of ChD. We sought to understand whether there was an association between anti-M2 mAChR autoantibody titers in patients with chronic ChD and the presence of distal cardiac conduction disorders or cardiac arrhythmias. We conducted a cross-sectional study in 79 patients from Argentina and Bolivia with chronic ChD without evident structural heart disease. Autoantibody titers were measured using indirect enzyme-linked immunosorbent assay. Elevated anti-M2 mAChR autoantibody titers were associated with the presence of distal conduction disease but not with cardiac arrhythmias. High anti-M2 mAChR autoantibody levels could assist with identifying early structural heart disease in patients with chronic ChD.
ISSN:0146-2806
1535-6280
DOI:10.1016/j.cpcardiol.2021.100820